A Study of Metformin to Improve Cardiac Function After LVAD Implantation

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 108 participants.

Also called NCT07666698

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 108 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07666698
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07666698. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-01 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Metformin to Improve Cardiac Function After LVAD Implantation
Condition
Heart Failure
Condition
Left Ventricular Assist Device
Intervention (Drug)
Metformin Hydrochloride
Intervention (Drug)
Placebo
Lead sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (class: other)

Record details

Record id
cardio:ct-nct07666698
Content hash
38efb7b4246bfe358c2f839156fc8ed615b905033e075ea6521395fe40d512de